Sector
Health
Historical revenue, net income, net margin and earnings per share of Coloplast A/S, year by year from 2010 to 2026. Market data, amounts in US dollars.
Revenue, net income, net margin, earnings per share (EPS) and revenue growth. Amounts in USD.
| Year | Revenue | Net income | Net margin | BPA | Revenue growth |
|---|---|---|---|---|---|
| 2010 | 1,41 billion $ | 183,28 M$ | 13,0 % | 0,86 $ | n/d |
| 2011 | 1,50 billion $ | 268,21 M$ | 17,9 % | 1,27 $ | +6,7 % |
| 2012 | 1,63 billion $ | 323,51 M$ | 19,9 % | 1,53 $ | +8,4 % |
| 2013 | 1,72 billion $ | 399,74 M$ | 23,3 % | 1,90 $ | +5,6 % |
| 2014 | 1,83 billion $ | 352,41 M$ | 19,2 % | 1,67 $ | +6,8 % |
| 2015 | 2,05 billion $ | 132,56 M$ | 6,5 % | 0,63 $ | +11,9 % |
| 2016 | 2,16 billion $ | 463,44 M$ | 21,4 % | 2,19 $ | +5,6 % |
| 2017 | 2,29 billion $ | 559,87 M$ | 24,4 % | 2,64 $ | +5,8 % |
| 2018 | 2,43 billion $ | 566,95 M$ | 23,4 % | 2,67 $ | +5,9 % |
| 2019 | 2,65 billion $ | 571,07 M$ | 21,6 % | 2,69 $ | +9,1 % |
| 2020 | 2,73 billion $ | 618,85 M$ | 22,6 % | 2,91 $ | +3,4 % |
| 2021 | 2,86 billion $ | 711,45 M$ | 24,8 % | 3,34 $ | +4,8 % |
| 2022 | 3,33 billion $ | 693,90 M$ | 20,8 % | 3,27 $ | +16,2 % |
| 2023 | 3,61 billion $ | 705,25 M$ | 19,5 % | 3,27 $ | +8,5 % |
| 2024 | 3,99 billion $ | 744,92 M$ | 18,7 % | 3,31 $ | +10,3 % |
| 2025 | 4,11 billion $ | 536,13 M$ | 13,0 % | 2,38 $ | +3,1 % |
| 2026 | 4,27 billion $ | 453,26 M$ | 10,6 % | 2,01 $ | +3,8 % |
Graphical representation of annual amounts (in USD).
Valuation and profitability; price ratios calculated based on the price of 13/11/2026.